BOOM
Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Curated database of commensal, symbiotic and pathogenic microbiota ✅
Generative Bioinformatics (Center of Excellence in Generative Medicine ) Vol: Issue Pages: Pub: 2014 Jun Epub: Authors D'Adamo Peter , |
|
|
Green tea polyphenol (epigallocatechin-3-gallate) improves gut dysbiosis and serum bile acids dysregulation in high-fat diet-fed mice. ✅
Go to Publication ✅
Journal of clinical biochemistry and nutrition (J Clin Biochem Nutr ) Vol: 65 Issue 1 Pages: 34-46 Pub: 2019 Jul Epub: 2019 Apr 6 Authors Ushiroda C , Naito Y , Takagi T , Uchiyama K , Mizushima K , Higashimura Y , Yasukawa Z , Okubo T , Inoue R , Honda A , Matsuzaki Y , Itoh Y , |
|
|
Epigallocatechin gallate alleviates osteoporosis by regulating the gut microbiota and serum metabolites in rats. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 14 Issue 23 Pages: 10564-10580 Pub: 2023 Nov 27 Epub: 2023 Nov 27 Authors Han X , Fu Y , Wang K , Li S , Jiang C , Wang S , Wang Z , Liu G , Hu S , |
|
|
Epigallocatechin gallate alleviates osteoporosis by regulating the gut microbiota and serum metabolites in rats. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 14 Issue 23 Pages: 10564-10580 Pub: 2023 Nov 27 Epub: 2023 Nov 27 Authors Han X , Fu Y , Wang K , Li S , Jiang C , Wang S , Wang Z , Liu G , Hu S , |
|
|
Epigallocatechin gallate alleviates osteoporosis by regulating the gut microbiota and serum metabolites in rats. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 14 Issue 23 Pages: 10564-10580 Pub: 2023 Nov 27 Epub: 2023 Nov 27 Authors Han X , Fu Y , Wang K , Li S , Jiang C , Wang S , Wang Z , Liu G , Hu S , |
|
|
Amelioration of cognitive impairment using epigallocatechin-3-gallate in ovariectomized mice fed a high-fat diet involves remodeling with Prevotella and Bifidobacteriales. ✅
Go to Publication ✅
Frontiers in pharmacology (Front Pharmacol ) Vol: 13 Issue Pages: 1079313 Pub: 2022 Epub: 2023 Jan 4 Authors Qu Y , Wu Y , Cheng W , Wang D , Zeng L , Wang Y , Li T , Zhang L , Yang J , Sun L , Ai J , |
|
|
Tea polyphenol and epigallocatechin gallate ameliorate hyperlipidemia via regulating liver metabolism and remodeling gut microbiota. ✅
Go to Publication ✅
Food chemistry (Food Chem ) Vol: 404 Issue Pt A Pages: 134591 Pub: 2023 Mar 15 Epub: 2022 Oct 14 Authors Wen JJ , Li MZ , Chen CH , Hong T , Yang JR , Huang XJ , Geng F , Hu JL , Nie SP , |
|
|
Epigallocatechin-3-Gallate Decreases Plasma and Urinary Levels of p-Cresol by Modulating Gut Microbiota in Mice. ✅
Go to Publication ✅
ACS omega (ACS Omega ) Vol: 7 Issue 44 Pages: 40034-40041 Pub: 2022 Nov 8 Epub: 2022 Oct 28 Authors Unno T , Ichitani M , |
|
|
Epigallocatechin-3-Gallate Decreases Plasma and Urinary Levels of p-Cresol by Modulating Gut Microbiota in Mice. ✅
Go to Publication ✅
ACS omega (ACS Omega ) Vol: 7 Issue 44 Pages: 40034-40041 Pub: 2022 Nov 8 Epub: 2022 Oct 28 Authors Unno T , Ichitani M , |
|
|
Dietary Epigallocatechin-3-Gallate Alters the Gut Microbiota of Obese Diabetic db/db Mice: Lactobacillus Is a Putative Target. ✅
Go to Publication ✅
Journal of medicinal food (J Med Food ) Vol: 23 Issue 10 Pages: 1033-1042 Pub: 2020 Oct Epub: Authors Park JM , Shin Y , Kim SH , Jin M , Choi JJ , |
|
|
Dietary Epigallocatechin-3-Gallate Alters the Gut Microbiota of Obese Diabetic db/db Mice: Lactobacillus Is a Putative Target. ✅
Go to Publication ✅
Journal of medicinal food (J Med Food ) Vol: 23 Issue 10 Pages: 1033-1042 Pub: 2020 Oct Epub: Authors Park JM , Shin Y , Kim SH , Jin M , Choi JJ , |
|
|
Dietary Epigallocatechin-3-Gallate Alters the Gut Microbiota of Obese Diabetic db/db Mice: Lactobacillus Is a Putative Target. ✅
Go to Publication ✅
Journal of medicinal food (J Med Food ) Vol: 23 Issue 10 Pages: 1033-1042 Pub: 2020 Oct Epub: Authors Park JM , Shin Y , Kim SH , Jin M , Choi JJ , |
|
|
Reciprocal Interactions between Epigallocatechin-3-gallate (EGCG) and Human Gut Microbiota In Vitro. ✅
Go to Publication ✅
Journal of agricultural and food chemistry (J Agric Food Chem ) Vol: 68 Issue 36 Pages: 9804-9815 Pub: 2020 Sep 9 Epub: 2020 Aug 26 Authors Liu Z , de Bruijn WJC , Bruins ME , Vincken JP , |
|
|
Long-term treatment with green tea polyphenols modifies the gut microbiome of female sprague-dawley rats. ✅
Go to Publication ✅
The Journal of nutritional biochemistry (J Nutr Biochem ) Vol: 56 Issue Pages: 55-64 Pub: 2018 Jun Epub: 2018 Jan 31 Authors Wang J , Tang L , Zhou H , Zhou J , Glenn TC , Shen CL , Wang JS , |
|
|
AFM probing the mechanism of synergistic effects of the green tea polyphenol (-)-epigallocatechin-3-gallate (EGCG) with cefotaxime against extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli. ✅
Go to Publication ✅
PloS one (PLoS One ) Vol: 7 Issue 11 Pages: e48880 Pub: 2012 Epub: 2012 Nov 13 Authors Cui Y , Kim SH , Kim H , Yeom J , Ko K , Park W , Park S , |
|
|
Phytochemical characterization, and antioxidant and antibacterial activities of the hydroethanolic extract of Anadenanthera peregrina stem bark. ✅
Go to Publication ✅
Brazilian journal of biology = Revista brasleira de biologia (Braz J Biol ) Vol: 82 Issue Pages: e234476 Pub: 2021 Epub: 2021 Mar 5 Authors Marinho TA , Oliveira MG , Menezes-Filho ACP , Castro CFS , Oliveira IMM , Borges LL , Melo-Reis PR , Silva-Jr NJ , |
|
|
Antibacterial efficacy of epigallocatechin-3-gallate cross-linked small intestinal submucosa guided bone regeneration membrane. ✅
Go to Publication ✅
Dental materials journal (Dent Mater J ) Vol: 42 Issue 5 Pages: 624-632 Pub: 2023 Sep 29 Epub: 2023 Aug 23 Authors Gou M , Zou C , Jiang Y , Xie H , Wang H , Song H , |
|
|
Antibacterial efficacy of epigallocatechin-3-gallate cross-linked small intestinal submucosa guided bone regeneration membrane. ✅
Go to Publication ✅
Dental materials journal (Dent Mater J ) Vol: 42 Issue 5 Pages: 624-632 Pub: 2023 Sep 29 Epub: 2023 Aug 23 Authors Gou M , Zou C , Jiang Y , Xie H , Wang H , Song H , |
|
|
Examination of sex-specific interactions between gut microbiota and host metabolism after 12-week combined polyphenol supplementation in individuals with overweight or obesity. ✅
Go to Publication ✅
Gut microbes (Gut Microbes ) Vol: 16 Issue 1 Pages: 2392875 Pub: 2024 Jan-Dec Epub: 2024 Aug 25 Authors Jardon KM , Goossens GH , Most J , Galazzo G , Venema K , Penders J , Blaak EE , |
|
|
Examination of sex-specific interactions between gut microbiota and host metabolism after 12-week combined polyphenol supplementation in individuals with overweight or obesity. ✅
Go to Publication ✅
Gut microbes (Gut Microbes ) Vol: 16 Issue 1 Pages: 2392875 Pub: 2024 Jan-Dec Epub: 2024 Aug 25 Authors Jardon KM , Goossens GH , Most J , Galazzo G , Venema K , Penders J , Blaak EE , |
|
|
Examination of sex-specific interactions between gut microbiota and host metabolism after 12-week combined polyphenol supplementation in individuals with overweight or obesity. ✅
Go to Publication ✅
Gut microbes (Gut Microbes ) Vol: 16 Issue 1 Pages: 2392875 Pub: 2024 Jan-Dec Epub: 2024 Aug 25 Authors Jardon KM , Goossens GH , Most J , Galazzo G , Venema K , Penders J , Blaak EE , |
|
|
Examination of sex-specific interactions between gut microbiota and host metabolism after 12-week combined polyphenol supplementation in individuals with overweight or obesity. ✅
Go to Publication ✅
Gut microbes (Gut Microbes ) Vol: 16 Issue 1 Pages: 2392875 Pub: 2024 Jan-Dec Epub: 2024 Aug 25 Authors Jardon KM , Goossens GH , Most J , Galazzo G , Venema K , Penders J , Blaak EE , |
|
|
Epicatechin gallate and its analogues interact with sortase A and ß-lactamase to suppress Staphylococcus aureus virulence. ✅
Go to Publication ✅
Frontiers in cellular and infection microbiology (Front Cell Infect Microbiol ) Vol: 15 Issue Pages: 1537564 Pub: 2025 Epub: 2025 Mar 25 Authors Teng F , Wang L , Wen J , Tian Z , Wang G , Peng L , |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
